Comparative effects of non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease on risk of incident cardiovascular events: a meta-analysis of about 13 million individuals
- PMID: 36002249
- DOI: 10.1136/gutjnl-2022-328224
Comparative effects of non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease on risk of incident cardiovascular events: a meta-analysis of about 13 million individuals
Keywords: CARDIOVASCULAR DISEASE; META-ANALYSIS; NONALCOHOLIC STEATOHEPATITIS.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?Gut. 2022 Feb;71(2):382-390. doi: 10.1136/gutjnl-2020-322564. Epub 2021 Feb 4. Gut. 2022. PMID: 33541866
Similar articles
-
Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease.Aliment Pharmacol Ther. 2020 Apr;51(7):728-736. doi: 10.1111/apt.15660. Epub 2020 Feb 11. Aliment Pharmacol Ther. 2020. PMID: 32043602 Free PMC article.
-
Frequency of Cardiovascular Events and Effect on Survival in Liver Transplant Recipients for Cirrhosis Due to Alcoholic or Nonalcoholic Steatohepatitis.Exp Clin Transplant. 2016 Feb;14(1):79-85. doi: 10.6002/ect.2015.0089. Epub 2015 Nov 17. Exp Clin Transplant. 2016. PMID: 26581602
-
Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps.Atherosclerosis. 2019 Mar;282:110-120. doi: 10.1016/j.atherosclerosis.2019.01.029. Epub 2019 Jan 30. Atherosclerosis. 2019. PMID: 30731283 Review.
-
Alcoholic and Nonalcoholic Fatty Liver Disease and Incident Hospitalization for Liver and Cardiovascular Diseases.Clin Gastroenterol Hepatol. 2020 Jan;18(1):205-215.e7. doi: 10.1016/j.cgh.2019.05.004. Epub 2019 May 11. Clin Gastroenterol Hepatol. 2020. PMID: 31085337
-
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Overlapping Mechanisms.Semin Liver Dis. 2021 Aug;41(3):235-247. doi: 10.1055/s-0041-1725022. Epub 2021 May 15. Semin Liver Dis. 2021. PMID: 33992031 Review.
Cited by
-
Effect of Statins for Primary Prevention of Cardiovascular Disease According to the Fatty Liver Index.J Epidemiol Glob Health. 2024 Feb 23. doi: 10.1007/s44197-024-00205-9. Online ahead of print. J Epidemiol Glob Health. 2024. PMID: 38393512
-
Unraveling the link between insulin resistance and Non-alcoholic fatty liver disease (or metabolic dysfunction-associated steatotic liver disease): A Narrative Review.J Diabetes Metab Disord. 2023 Sep 8;22(2):1083-1094. doi: 10.1007/s40200-023-01293-3. eCollection 2023 Dec. J Diabetes Metab Disord. 2023. PMID: 37975107 Review.
-
Dietary strategies in non-alcoholic fatty liver disease patients: From evidence to daily clinical practice, a systematic review.United European Gastroenterol J. 2023 Sep;11(7):663-689. doi: 10.1002/ueg2.12443. Epub 2023 Jul 25. United European Gastroenterol J. 2023. PMID: 37491835 Free PMC article. Review.
-
An international multidisciplinary consensus statement on MAFLD and the risk of CVD.Hepatol Int. 2023 Aug;17(4):773-791. doi: 10.1007/s12072-023-10543-8. Epub 2023 May 19. Hepatol Int. 2023. PMID: 37204656 Free PMC article.
-
Comprehensive Review of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease.J Cardiovasc Dev Dis. 2022 Nov 26;9(12):419. doi: 10.3390/jcdd9120419. J Cardiovasc Dev Dis. 2022. PMID: 36547416 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical